TAYSHA GENE THERAPIES INC (TSHA) — institutional ownership
220 funds reported holding TAYSHA GENE THERAPIES INC in their latest 13F filings, worth $2.15B in total (CUSIP 877619106).
Largest holders
- Avoro Capital Advisors LLC — $163M
- RA CAPITAL MANAGEMENT, L.P. — $160M
- GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) — $155M
- BlackRock, Inc. (BLK) — $141M
- Vestal Point Capital, LP — $132M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $112M
- RTW INVESTMENTS, LP — $92.3M
- FMR LLC — $90.8M
- VANGUARD CAPITAL MANAGEMENT LLC — $85.0M
- STATE STREET CORP (STT, STT-PG) — $77.8M
Famous investors holding it
- D. E. Shaw portfolio (D. E. Shaw & Co.)
- Izzy Englander portfolio (Millennium Management)
- Ken Griffin portfolio (Citadel Advisors)
- Two Sigma portfolio (Two Sigma Investments)
Insider buying and selling at TAYSHA GENE THERAPIES INC
Who owns the most TSHA stock?
The largest institutional holders in the latest 13F filings are Avoro Capital Advisors LLC ($163M), RA CAPITAL MANAGEMENT, L.P. ($160M), GOLDMAN SACHS GROUP INC (GS, GSCE, GS-PA, GS-PC, GS-PD) ($155M).
How many funds own TSHA?
220 funds reported holding it, worth $2.15B in total.